Zydus’ Plasmid DNA-based Covid-19 vaccine authorised in India
Zydus claims that its ZyCoV-D is the world's first plasmid DNA vaccine for Covid-19, with well-established safety, efficacy…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
23 Aug 21
Zydus claims that its ZyCoV-D is the world's first plasmid DNA vaccine for Covid-19, with well-established safety, efficacy…
20 Aug 21
The EC approval for Abecma is based KarMMa trial, which showed rapid, deep and durable responses with a…
19 Aug 21
The US FDA approved Jardiance based on results from the Phase 3 EMPEROR-Reduced trial, in which the drug…
18 Aug 21
Cosentyx was previously approved in China for the treatment of moderate-to-severe plaque psoriasis and ankylosing spondylitis in adults
18 Aug 21
Spikevax vaccine, previously called Covid-19 Vaccine Moderna, was already approved in the UK, for active immunisation in adults…
17 Aug 21
Initial data was submitted from Phase 1 of the Phase 1/2/3 clinical trial programme, evaluating the third dose…
16 Aug 21
The company is working to optimise production of Welireg, which is an oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor,…
16 Aug 21
The immunogenicity of Ticovac was assessed in clinical studies across the population aged between 1 to 15 years…
13 Aug 21
Durezol is a topical corticosteroid, indicated for inflammation and pain associated with ocular surgery, and for endogenous anterior…
12 Aug 21
The FDA approval is based on Phase 3 CLEAR/KEYNOTE-581 trial, in which Keytruda plus Lenvima combination was superior…